Literature DB >> 32859518

CNS vasculopathies: Challenging mimickers of primary angiitis of the central nervous system.

Tracey A Cho1, Ann Jones2.   

Abstract

Primary angiitis of the central nervous system (CNS) is an inflammatory vasculopathy affecting the brain and spinal cord. It is a difficult diagnosis to make because of its insidious nonspecific course and its multiple mimics. This review identifies and discusses some noninfectious mimickers of primary CNS angiitis, including: reversible cerebral vasoconstriction syndrome, Sneddon's Syndrome, amyloid-beta-related angiopathy, Susac Syndrome, and neurosarcoidosis. Each condition will be reviewed in terms of epidemiology, pathology, clinical presentation, diagnostic approach, and treatment. Distinguishing these mimics from the primary angiitis of the CNS is important for proper treatment and prognosis.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amyloid-beta-related angiopathy; Cerebral vasculitis; Cerebral vasculopathy; Neurosarcoidosis; Primary angiitis of the central nervous system; Reversible cerebral vasoconstriction syndrome; Sneddon's syndrome; Susac syndrome

Mesh:

Year:  2020        PMID: 32859518     DOI: 10.1016/j.berh.2020.101569

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  2 in total

Review 1.  Central and Peripheral Nervous System Complications of Vasculitis Syndromes From Pathology to Bedside: Part 1-Central Nervous System.

Authors:  Gelsomina Mansueto; Giuseppe Lanza; Francesco Fisicaro; Danielle Alaouieh; Emily Hong; Sara Girolami; Marco Montella; Alessandro Feola; Mario Di Napoli
Journal:  Curr Neurol Neurosci Rep       Date:  2022-02-09       Impact factor: 6.030

2.  Isolated arteritis misdiagnosed as bilateral orbital tumors in a patient with acute ischemic stroke.

Authors:  Edyta Dziadkowiak; Justyna Chojdak-Łukasiewicz; Bogusław Paradowski; Joanna Bladowska
Journal:  Radiol Case Rep       Date:  2022-08-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.